The deal includes 14 return centers and approximately 800 employees, expanding DHL’s presence in the U.S. healthcare supply chain, according to a Jan. 9 news release from the company.
The acquisition enhances DHL’s ability to manage returns for healthcare products, which is increasingly important as e-commerce and direct-to-consumer models grow within the sector.
Inmar will retain its pharmaceutical reverse distribution business, while DHL will have access to Inmar’s technology-driven logistics solutions.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
